Cannabinoid Industry

cbdMD, Inc. will host an earnings call on February 17, 2026, to discuss Q1 2026 financial results and operational progress. The discussion will cover performance across their diverse product lines, including THC-free CBD, Delta-9, pet products, functional mushrooms, and their new THC-infused seltzer, Herbal Oasis. Investors will seek insights into their market strategy and competitive positioning within the evolving cannabinoid industry. A webcast and dial-in option are available.